sPD-L1 isolated from the supernatants of PD-L1-positive tumor cell lines retains the extracellular PD-1 binding domain, as evidenced through tandem mass spectrometry (17), and its binding activity to the PD-1 receptor (14). This evidence concerns the gene SPDL1 and neoplasm.